SMARCA1 and neoplasm: The SWI/SNF complex typically promotes chromatin access via repositioning, ejecting nucleosomes and evicting histone dimers to activate or repress gene expression and to facilitate DNA damage repair (Figure 2A); thus, the genetic abnormality of these complexes is closely related to tumor progression and treatment outcomes.